Publication: Comparison of the protective effects of various antiulcer agents alone or in combination on indomethacin-induced gastric ulcers in rats
| dc.contributor.author | OKUYAN, BETÜL | |
| dc.contributor.author | SANCAR, MESUT | |
| dc.contributor.author | RABUŞ, ŞULE | |
| dc.contributor.authors | Izzettin, Fikret Vehbi; Sancar, Mesut; Okuyan, Betul; Apikoglu-Rabus, Sule; Cevikbas, Ugur | |
| dc.date.accessioned | 2022-03-12T18:06:02Z | |
| dc.date.accessioned | 2026-01-11T14:41:14Z | |
| dc.date.available | 2022-03-12T18:06:02Z | |
| dc.date.issued | 2012 | |
| dc.description.abstract | The aim of this study which was structured with the objective of determination of the optimum protective therapy against the long term NSAID therapy-induced ulcers was to compare the gastro-protective effects of various antiulcer drugs (ranitidine, omeprazole, bismuth and misoprostol)alone or in combination with each other in different doses on indomethacin-induced gastric ulcers in rats. In this experimental study the protective effect of misoprostol (100 mu g/kg/day and 10 mu g/kg/day i.g.), omeprazole (5 mg/kg/day and 1.5 mg/kg/day i.p.), ranitidine (40 mg/kg/day and 10 mg/kg/day i.p.), bismuth (70 mg/kg/day and 15 mg/kg/day i.g.), combinations of misoprostol (10 mu g/kg/day i.g.) plus omeprazole (1.5 mg/kg/day i.p.) and misoprostol (10 mu g/kg/day i.g.) plus ranitidine (10 mg/kg/day i.p.) are investigated on indomethacin (50 mg/kg/day s.c.) induced gastric ulcers. Half an hour before indomethacin administration, each group received the above treatment regimens for 5 days. After 5-day treatment, the rats were sacrificed and histopathological and hematological examinations were performed. The following regimens were found to be effective in the prevention of indomethacin-induced gastric lesions: 100 mu g/kg misoprostol, 10 mu g/kg misoprostol, 5 mg/kg omeprazole, combination of 10 mu g/kg misoprostol plus 1.5 mg/kg omeprazole and 10 mu g/kg misoprostol plus 10 mg/kg ranitidine. The prevention rates achieved by these treatments were 71.4%, 50%, 47.6%, 52.4% and 50%, respectively. As a result of this study, misoprostol and omeprazol were found to be effective in protection against NSAID-induced gastric problems: while, ranitidine and bismuth were not. Also, the combinations of these agents were not found to have additive or synergistic effects. (C) 2010 Elsevier GmbH. All rights reserved. | |
| dc.identifier.doi | 10.1016/j.etp.2010.09.007 | |
| dc.identifier.eissn | 1618-1433 | |
| dc.identifier.issn | 0940-2993 | |
| dc.identifier.pubmed | 21030227 | |
| dc.identifier.uri | https://hdl.handle.net/11424/230824 | |
| dc.identifier.wos | WOS:000304332700009 | |
| dc.language.iso | eng | |
| dc.publisher | ELSEVIER GMBH | |
| dc.relation.ispartof | EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Indomethacin-induced gastric ulcer | |
| dc.subject | Omeprazole | |
| dc.subject | Misoprostol | |
| dc.subject | Ranitidine | |
| dc.subject | Bismuth | |
| dc.subject | Rat | |
| dc.subject | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | |
| dc.subject | OMEPRAZOLE | |
| dc.subject | MISOPROSTOL | |
| dc.subject | PREVENTION | |
| dc.subject | CIMETIDINE | |
| dc.subject | SUCRALFATE | |
| dc.subject | ASPIRIN | |
| dc.subject | THERAPY | |
| dc.title | Comparison of the protective effects of various antiulcer agents alone or in combination on indomethacin-induced gastric ulcers in rats | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 343 | |
| oaire.citation.issue | 4 | |
| oaire.citation.startPage | 339 | |
| oaire.citation.title | EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY | |
| oaire.citation.volume | 64 |
